HD-OPM Archive
Topics › Aging & longevity

Six non-diabetes benefits of metformin shown in trials, and the TAME aging hypothesis

Louis Nervegna · Aug 24, 2024 · ♥ 20 reactions · 29 comments · original Facebook post
Aging & longevityInsulin resistance & diabetes
AI summary & key facts

The post lists six effects of metformin reported in randomized trials of non-diabetics (long Covid, Covid outcomes, periodontal disease, muscle loss, knee osteoarthritis pain, oral pre-cancer lesions) and argues they share aging as a risk factor. It mentions a monkey study and the planned TAME trial testing whether metformin slows aging; most evidence is linked via Facebook shares.

Randomized controlled trials in humans have demonstrated that the diabetes drug metformin does 6 things, which are completely unrelated to diabetes.

In all 6 cases, the trials were in non-diabetics.

  1. It reduces the risk for long Covid by a lot.

facebook.com/share/p/QLqVMuWzC54Wuyxm

  1. It improves Covid outcomes.

facebook.com/share/p/mxdwMc21YZi4iJbQ

  1. It prevents age-related periodontal disease.

facebook.com/share/p/qrWFthGgsUbYA8x3

(There is lots of data that rapamycin prevents periodontal disease in mice by slowing aging, but it is unproven in humans so far. Metformin is actually proven to do this in humans.)

  1. It prevents age-related muscle loss and sarcopenia, associated with disuse.

facebook.com/share/p/WMLqhkfc2wkYb8vm

  1. It significantly reduces pain in osteoarthritis of the knee.

↪ Metformin eased knee osteoarthritis pain more than placebo in a 6-month Australian RCT

facebook.com/share/v/1EawozwqEK

  1. It reverses pre-cancerous lesions in the mouth, by inhibiting mTOR signaling.

↪ Metformin gave 60% histological response in oral premalignant lesions (phase IIa)

—————-

At first glance, these 6 things have nothing in common.

But a major risk factor for all of these conditions is AGING.

It is very possible that metformin is working by treating some aspects of the underlying aging process itself, which is a root cause of these seemingly unrelated conditions.

A recent study in monkeys appears to indicate that this is true:

↪ Metformin slowed brain aging in monkeys, with neurons resembling those 6 years younger

↪ Nature review: metformin improved aging parameters in old male monkeys

There is a clinical trial called TAME which aims to test the hypothesis that metformin slows the aging process in humans, as it relates to causing age-related diseases and conditions.

You can learn more about the TAME trial here:

afar.orgLink to afar.orgafar.org

#metforminHD #tameHD #agingHD #longevityHD #metformincovidHD

Research cited

← newer: Two Harvard studies found no extra birth-defect risk with meolder: Taller people tend to live shorter lives, likely via growth →